Evidence map›Paper›PMID 34832527›Full record

ArticlePathogens (Basel, Switzerland)2021

Assessment of Ceragenins in Prevention of Damage to Voice Prostheses Caused by

Jakub Spałek, Tamara Daniluk, Adrian Godlewski, Piotr Deptuła, Urszula Wnorowska, Dominika Ziembicka, Mateusz Cieśluk, Krzysztof Fiedoruk, Michał Ciborowski, Adam Krętowski and 5 more

Open access · goldAbstract read
In one paragraph

Article in Pathogens (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 15 citations in OpenAlex.

  1. Microbial colonization of tracheostoma region in patients with voice prostheses - double-blind randomized clinical trial.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2026
    Trial
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Investigating the Effectiveness of Ceragenins againstInternational journal of molecular sciences · 2024
    Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 2 countries.

Jakub SpałekInstitute of Medical Science, Collegium Medicum, Jan Kochanowski University of Kielce, IX Wieków Kielc 19A, 25-317 Kielce, Poland.ORCID 0000-0002-8943-4408
Tamara DanilukDepartment of Medical Microbiology and Nanobiomedical Engineering, Medical University of Bialystok, Mickiewicza 2C, 15-222 Bialystok, Poland.
Adrian GodlewskiMetabolomics Laboratory, Clinical Research Centre, Medical University of Białystok, 15-089 Białystok, Poland.ORCID 0000-0003-2147-2552
Piotr DeptułaDepartment of Medical Microbiology and Nanobiomedical Engineering, Medical University of Bialystok, Mickiewicza 2C, 15-222 Bialystok, Poland.
Urszula WnorowskaDepartment of Medical Microbiology and Nanobiomedical Engineering, Medical University of Bialystok, Mickiewicza 2C, 15-222 Bialystok, Poland.
Dominika ZiembickaDepartment of Public Health, Medical University of Białystok, 15-089 Białystok, Poland.
Mateusz CieślukDepartment of Medical Microbiology and Nanobiomedical Engineering, Medical University of Bialystok, Mickiewicza 2C, 15-222 Bialystok, Poland.ORCID 0000-0002-5931-4376
Krzysztof FiedorukDepartment of Medical Microbiology and Nanobiomedical Engineering, Medical University of Bialystok, Mickiewicza 2C, 15-222 Bialystok, Poland.ORCID 0000-0001-7343-8837
Michał CiborowskiMetabolomics Laboratory, Clinical Research Centre, Medical University of Białystok, 15-089 Białystok, Poland.ORCID 0000-0003-3729-0518
Adam KrętowskiMetabolomics Laboratory, Clinical Research Centre, Medical University of Białystok, 15-089 Białystok, Poland.ORCID 0000-0002-4522-4978
Stanisław GóźdźInstitute of Medical Science, Collegium Medicum, Jan Kochanowski University of Kielce, IX Wieków Kielc 19A, 25-317 Kielce, Poland.
Bonita DurnaśInstitute of Medical Science, Collegium Medicum, Jan Kochanowski University of Kielce, IX Wieków Kielc 19A, 25-317 Kielce, Poland.
Paul B SavageDepartment of Chemistry and Biochemistry, Brigham Young University, Provo, UT 84602, USA.
Sławomir OkłaInstitute of Medical Science, Collegium Medicum, Jan Kochanowski University of Kielce, IX Wieków Kielc 19A, 25-317 Kielce, Poland.
Robert BuckiDepartment of Medical Microbiology and Nanobiomedical Engineering, Medical University of Bialystok, Mickiewicza 2C, 15-222 Bialystok, Poland.ORCID 0000-0001-7664-9226
Medical University of Białystok · PLJan Kochanowski University · PLBrigham Young University · US

Funding

National Science Centre, Poland (UMO-2018/31/B/NZ6/02476 to RB) Medical University of Bialystok (SUB/1/DN/20/001/1122 to MC) 024/RID/2018/19Part of the study was conducted with the use of equipment purchased by the Medical University of Białystok as part of the RPOWP 2007-2013 funding, Priority I, Axis 1.1 UDA- RPPD.01.01.00-20-001/15-00 dated 26.06.2015
6 · The paper itself

Abstract

This study aimed to investigate the potential application of ceragenins (CSAs) as new candidacidal agents to prevent biofilm formation on voice prostheses (VPs). The deterioration of the silicone material of VPs is caused by biofilm growth on the device which leads to frequent replacement procedures and sometimes serious complications. A significant proportion of these failures is caused by

Indexed as

biofilmCandida spp.cerageninsimpregnationsiliconevoice prostheses

Identifiers

PMID34832527
PMCPMC8622639
OpenAlexW3208078883

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.